Differences in Uptravi maintenance doses had no impact on the risk of hospitalization among adults with PAH, a claims ...

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Investigators say more research is warranted to optimize management of patients with pulmonary arterial hypertension (PAH) ...

Discover Insmed Inc.'s groundbreaking patent for treating Mycobacterium avium complex lung infections with a novel aerosolized amikacin method, promising improved outcomes.

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five presentations and one poster across its commercial and development portfolio will be presented ...